Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA)

NCT07109180 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-08-07

No results posted yet for this study

Summary

PANACOTTA is a multicenter randomized controlled trial including patients with symptomatic chronic pancreatitis and a dilated main pancreatic duct to either robot-assisted or open lateral pancreaticojejunostomy. The PANACOTTA trial will assess the post-operative quality of recovery following robot-assisted versus open lateral pancreaticojejunostomy.

Conditions

  • Chronic Pancreatitis
  • Surgery
  • Minimally Invasive Surgical Technique
  • Robot Surgica
  • Robot Surgery
  • Minimally Invasive Surgery
  • Pancreaticojunostomy

Interventions

PROCEDURE

Robot-assisted lateral pancreaticojejunostomy

Robot-assisted

PROCEDURE

Open lateral pancreaticojejunostomy

Open surgery

Sponsors & Collaborators

  • St. Antonius Hospital

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • Onze Lieve Vrouwe Gasthuis

    collaborator OTHER
  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER
  • Radboud University Medical Center

    collaborator OTHER
  • Medisch Spectrum Twente

    collaborator OTHER
  • Leiden University Medical Center

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • M.G. Besselink, Amsterdam UMC · prof. dr.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-16
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07109180 on ClinicalTrials.gov